New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx DOI Creative Commons
Sagar Changela,

Samad Ashraf,

Justin Y. Lu

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Dec. 30, 2024

This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. retrospective included 35,102 COVID-19 patients 682,594 contemporary non-COVID-19 without past medical history GID (controls) from Montefiore Health System in Bronx (3/1/2020 7/31/2023). Comparisons were made unmatched propensity-matched (1:2) controls. The primary outcome was which peptic ulcer, inflammatory bowel disease, irritable syndrome, diverticulosis, diverticulitis, biliary disease. Multivariate Cox proportional hazards model analysis performed adjustment for covariates. There 2,228 (6.34%) positive who developed compared 38,928 (5.70%) had an elevated developing (adjusted HR = 1.18 (95% CI 1.12-1.25) controls, after adjusting confounders that smoking, obesity, diabetes, hypertension. These findings underscore need additional research follow-up at-risk individuals post infection.

Language: Английский

Mortality and COVID Infection: Predictors of Mortality 10 Months after Discharge DOI Creative Commons
Víctor Eugenio Vera-Delgado,

Dácil García-Rosado,

Onán Pérez‐Hernández

et al.

Diseases, Journal Year: 2024, Volume and Issue: 12(6), P. 123 - 123

Published: June 5, 2024

Background: The long-term survival of patients hospitalized with COVID-19 and the factors associated poorer months after infection are not well understood. aims present study were to analyze overall mortality 10 admission. Methods: 762 disease included. Patients underwent a complete clinical evaluation, routine laboratory analysis chest X-ray. Data collected included demographic data, such as vascular risk factors, tobacco or alcohol use, comorbidity, institutionalization. Results: Ten-month was 25.6%: 108 deaths occurred in-hospital, while 87 died discharge. In-hospital independently related NT-proBNP values > 503.5 pg/mL [OR = 4.67 (2.38–9.20)], urea 37 mg/dL [3.21 (1.86–7.31)] age older than 71 years 1.93 (1.05–3.54)]. 5.00 (3.06–8.19)], [3.51 (1.97–6.27)], cognitive impairment 1.96 (1.30–2.95), cancer 2.23 (1.36–3.68), leukocytes 6330/mm3 1.64 (1.08–2.50)], mortality. Conclusions: death remains high even infection. Overall during hospital discharge is nearly that observed Comorbidities impairment, organ dysfunction inflammatory reaction independent prognostic markers

Language: Английский

Citations

1

Long-Term Outcomes of Patients with Pre-Existing Essential Tremor After SARS-CoV-2 Infection DOI Creative Commons

Rachel Pakan,

Roham Hadidchi,

Yousef Al‐Ani

et al.

Diagnostics, Journal Year: 2024, Volume and Issue: 14(24), P. 2774 - 2774

Published: Dec. 10, 2024

Although COVID-19 has been linked to worse outcomes in patients with neurological disorders, its impact on those essential tremor (ET) remains unclear. To investigate clinical of ET and without three a half years post-pandemic. 1074 were evaluated this retrospective study the Montefiore Health System from January 2016 July 2023. Comparisons between positive SARS-CoV-2 polymerase chain reaction test made. Outcomes included post-index date major adverse cardiovascular events (MACEs), new-onset sleep disturbances, fatigue, dyspnea, first-time fall, anxiety, depression, headache, imbalance, mild cognitive impairment, all-cause mortality, adjusted hazard ratios (aHR) adjusting for covariates calculated. had higher prevalence pre-existing type-2 diabetes, anxiety compared COVID-19. was significantly associated risk MACEs, (aHR = 2.39 [1.49, 3.82]), disturbance, 2.12 [1.44, 3.13]), 1.83 [1.27, 2.65]), 1.98 [1.40, 2.80]), 4.76 [2.24, 10.14]), 3.66 [2.02, 6.64]), 2.38 [1.20, 4.70]). not mortality. In ET, increases several long-term health outcomes, but

Language: Английский

Citations

1

New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx DOI Creative Commons
Sagar Changela,

Samad Ashraf,

Justin Y. Lu

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Dec. 30, 2024

This study examined the incidence, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-CoV-2 infection up to 3.5 years post-infection. retrospective included 35,102 COVID-19 patients 682,594 contemporary non-COVID-19 without past medical history GID (controls) from Montefiore Health System in Bronx (3/1/2020 7/31/2023). Comparisons were made unmatched propensity-matched (1:2) controls. The primary outcome was which peptic ulcer, inflammatory bowel disease, irritable syndrome, diverticulosis, diverticulitis, biliary disease. Multivariate Cox proportional hazards model analysis performed adjustment for covariates. There 2,228 (6.34%) positive who developed compared 38,928 (5.70%) had an elevated developing (adjusted HR = 1.18 (95% CI 1.12-1.25) controls, after adjusting confounders that smoking, obesity, diabetes, hypertension. These findings underscore need additional research follow-up at-risk individuals post infection.

Language: Английский

Citations

1